Fig. 9: The roles of the CCL3–CCR5 axis on Ang II-induced AAA formation.

a Systolic blood pressure at the indicate time points after Ang II infusion (Pre: n = 7 in each mouse strain; 2 week: n = 9 in WT mice, n = 4 each in Ccl3−/− and Ccr1−/−, n = 5 in Ccr5−/− mice; 4 week: n = 4 each in WT, Ccr1−/−, and Ccr5−/−mice, n = 5 in Ccl3−/− mice). b Representative macroscopic appearance of the aorta in each mouse strain after Ang II infusion. c The diameters of the aorta in mice at 4 weeks after Ang II infusion (Pre: n = 6 each in WT and Ccl3−/− mice, n = 5 each in Ccr1−/− and Ccr5−/−mice; 4 week: n = 12 each in WT and Ccr5−/−mice, n = 14 in Ccl3−/− mice, n = 10 in Ccr1−/− mice). **P < 0.01, *P < 0.05, vs. posttreatment in WT mice. d Incidence of AAA in WT, Ccl3−/−, Ccr1−/−, and Ccr5−/− mice after Ang II infusion. *P < 0.05, vs. WT. e Histopathological analysis of the aortas obtained from WT, Ccl3−/−, Ccr1−/−, and Ccr5−/− mice after Ang II application. f Intra-aortic MMP-9 activities were measured by gelatin zymography on day 5 after Ang II infusion. M molecular weight marker. 1 and 5, WT; 2 and 6, Ccl3−/−; 3 and 7, Ccr1−/−; 4 and 8, Ccr5−/−. Independent experiments were repeated four times. Unpaired two-sided Student’s t test was used in (a) Steel–Dwass’s multiple comparison test was used in (d). Data are presented as mean values ± SEM.